ClinicalTrials.Veeva

Menu

Enhanced Triage for COVID-19 (ETC-19)

University Health Network, Toronto logo

University Health Network, Toronto

Status

Completed

Conditions

COVID-19
SARS-CoV 2

Study type

Observational

Funder types

Other

Identifiers

NCT04750369
20-5225

Details and patient eligibility

About

This study is to evaluate of the accuracy of biomarkers (i.e. circulating endothelial and immune activation markers) that indicate progression to severe disease in patients with suspected COVID-19 in the Emergency Department. It is a prospective observational study of patients presenting to emergency departments with a clinical suspicion of COVID19. All participants will have plasma samples collected for biomarker analysis, and will be tested for SARS-CoV-2 infection with a nasopharyngeal swab. Participants will be managed according to the best local practices.

Enrollment

806 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients presenting with clinical suspicion of COVID-19 infection, as per UHN case definition at the time of presentation
  • Age >18 years
  • Ability to provide verbal informed consent

Exclusion criteria

  • Patients who are not suspected of COVID-19 infection, as per UHN definition at the time of presentation

Trial contacts and locations

3

Loading...

Central trial contact

Sharaniyaa Balachandran

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems